# Prospective Sibling Oocyte Study of a New Method to Improve Embryo Development in IVF/ICSI Patients

> **NCT05680363** · NA · COMPLETED · sponsor: **Fecundis S.A.** · enrollment: 41 (actual)

## Conditions studied

- Infertility

## Interventions

- **DEVICE:** HyperSperm
- **DEVICE:** Standard Sperm Preparation

## Key facts

- **NCT ID:** NCT05680363
- **Lead sponsor:** Fecundis S.A.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-01
- **Primary completion:** 2025-12-18
- **Final completion:** 2025-12-18
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2026-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05680363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05680363, "Prospective Sibling Oocyte Study of a New Method to Improve Embryo Development in IVF/ICSI Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05680363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*